Company profile for LIPUM

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Lipum AB is a clinical-stage biopharmaceutical company focused on developing novel treatments for chronic inflammatory diseases. Its lead candidate, SOL-116, is a humanized monoclonal antibody targeting Bile Salt-Stimulated Lipase (BSSL), a previously overlooked immune system molecule. Currently in clinical trials with strong preclinical data for rheumatoid arthritis, SOL-116 is also being explored for other inflammatory condi...
Lipum AB is a clinical-stage biopharmaceutical company focused on developing novel treatments for chronic inflammatory diseases. Its lead candidate, SOL-116, is a humanized monoclonal antibody targeting Bile Salt-Stimulated Lipase (BSSL), a previously overlooked immune system molecule. Currently in clinical trials with strong preclinical data for rheumatoid arthritis, SOL-116 is also being explored for other inflammatory conditions with high unmet needs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Sweden
Address
Address
Tvistevägen 48C SE-907 36 Umeå
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty